Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes

References

• Arjmand, S., Behzadi, M., Kohlmeier, K. A., Mazhari, S., Sabahi, A., & Shabani, M. (2019). Bipolar disorder and the endocannabinoid system. Acta Neuropsychiatrica, 31(4), 193–201. https://doi.org/https://doi.org/10.1017/neu.2019.21
   PubMed Web of Science ®Google Scholar
• Arora, K., Qualls, S. H., Bobitt, J., Lum, H. D., Milavetz, G., Croker, J., & Kaskie, B. (2020). Measuring attitudes toward medical and recreational cannabis among older adults in Colorado. The Gerontologist, 60(4), e232–e241. https://doi.org/https://doi.org/10.1093/geront/gnz054
   PubMed Web of Science ®Google Scholar
• Arts, B., Simons, C. J., Drukker, M., & van Os, J. (2013). Antipsychotic medications and cognitive functioning in bipolar disorder: Moderating effects of COMT Val108/158 Met genotype. BMC Psychiatry, 13(1), 63. https://doi.org/https://doi.org/10.1186/1471-244X-13-63
   PubMedGoogle Scholar
• Bartoli, F., Crocamo, C., & Carrà, G. (2019). Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis. Neuroscience and Biobehavioral Reviews, 103, 14–20. https://doi.org/https://doi.org/10.1016/j.neubiorev.2019.05.017
   PubMed Web of Science ®Google Scholar
• Bedse, G., Hartley, N. D., Neale, E., Gaulden, A. D., Patrick, T. A., Kingsley, P. J., Uddin, M. J., Plath, N., Marnett, L. J., & Patel, S. (2017). Functional redundancy between canonical endocannabinoid signaling systems in the modulation of anxiety. Biological Psychiatry, 82(7), 488–499. https://doi.org/https://doi.org/10.1016/j.biopsych.2017.03.002
   PubMed Web of Science ®Google Scholar
• Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins Verbal Learning Test – Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12(1), 43–55. https://doi.org/https://doi.org/10.1076/clin.12.1.43.1726
   Web of Science ®Google Scholar
• Bluett, R. J., Báldi, R., Haymer, A., Gaulden, A. D., Hartley, N. D., Parrish, W. P., Baechle, J., Marcus, D. J., Mardam-Bey, R., Shonesy, B. C., Uddin, M. J., Marnett, L. J., Mackie, K., Colbran, R. J., Winder, D. G., & Patel, S. (2017). Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. Nature Communications, 8(1), 14782 https://doi.org/https://doi.org/10.1038/ncomms14782
   PubMedGoogle Scholar
• Bowe, A., & Rosenheck, R. (2015). PTSD and substance use disorder among veterans: Characteristics, service utilization and pharmacotherapy. Journal of Dual Diagnosis, 11(1), 22–32. https://doi.org/https://doi.org/10.1080/15504263.2014.989653
   PubMed Web of Science ®Google Scholar
• Braga, R. J., Burdick, K. E., DeRosse, P., & Malhotra, A. K. (2012). Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Research, 200(2–3), 242–245. https://doi.org/https://doi.org/10.1016/j.psychres.2012.05.025
   PubMed Web of Science ®Google Scholar
• Brandt, J. (1991). The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. Clinical Neuropsychologist, 5(2), 125–142. https://doi.org/https://doi.org/10.1080/13854049108403297
   Google Scholar
• Carliner, H., Brown, Q. L., Sarvet, A. L., & Hasin, D. S. (2017). Cannabis use, attitudes, and legal status in the U.S.: A review. Preventive Medicine, 104, 13–23. https://doi.org/https://doi.org/10.1016/j.ypmed.2017.07.008
   PubMed Web of Science ®Google Scholar
• Carrà, G., Bartoli, F., Crocamo, C., Brady, K. T., & Clerici, M. (2014). Attempted suicide in people with co-occurring bipolar and substance use disorders: Systematic review and meta-analysis. Journal of Affective Disorders, 167, 125–135. https://doi.org/https://doi.org/10.1016/j.jad.2014.05.066
   PubMed Web of Science ®Google Scholar
• Cassidy, F., Ahearn, E. P., & Carroll, B. J. (2001). Substance abuse in bipolar disorder. Bipolar Disorders, 3(4), 181–188. https://doi.org/https://doi.org/10.1034/j.1399-5618.2001.30403.x
   PubMed Web of Science ®Google Scholar
• Clementz, B. A., Sweeney, J. A., Hamm, J. P., Ivleva, E. I., Ethridge, L. E., Pearlson, G. D., Keshavan, M. S., & Tamminga, C. A. (2016). Identification of distinct psychosis biotypes using brain-based biomarkers. The American Journal of Psychiatry, 173(4), 373–384. https://doi.org/https://doi.org/10.1176/appi.ajp.2015.14091200
   PubMed Web of Science ®Google Scholar
• Cougle, J. R., Bonn-Miller, M. O., Vujanovic, A. A., Zvolensky, M. J., & Hawkins, K. A. (2011). Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychology of Addictive Behaviors, 25(3), 554–558. https://doi.org/https://doi.org/10.1037/a0023076
   PubMed Web of Science ®Google Scholar
• Dalton, E. J., Cate-Carter, T. D., Mundo, E., Parikh, S. V., & Kennedy, J. L. (2003). Suicide risk in bipolar patients: The role of co-morbid substance use disorders. Bipolar Disorders, 5(1), 58–61. https://doi.org/https://doi.org/10.1034/j.1399-5618.2003.00017.x
   PubMed Web of Science ®Google Scholar
• De Aquino, J. P., Sherif, M., Radhakrishnan, R., Cahill, J. D., Ranganathan, M., & D’Souza, D. C. (2018). The psychiatric consequences of cannabinoids. Clinical Therapeutics, 40(9), 1448–1456. https://doi.org/https://doi.org/10.1016/j.clinthera.2018.03.013
   PubMed Web of Science ®Google Scholar
• de la Fuente-Tomás, L., Arranz, B., Velasco, A., Sierra, P., Sanchez-Autet, M., García-Blanco, A., Safont, G., & García-Portilla, M. P. (2020). Sex differences in bipolar disorder: Impact of lifetime cannabis use on clinical course, functioning, and quality of life in bipolar disorder. Journal of Affective Disorders, 266, 258–262. https://doi.org/https://doi.org/10.1016/j.jad.2020.01.043
   PubMed Web of Science ®Google Scholar
• D’Souza, D. C., Braley, G., Blaise, R., Vendetti, M., Oliver, S., Pittman, B., Ranganathan, M., Bhakta, S., Zimolo, Z., Cooper, T., & Perry, E. (2008). Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of delta-9-tetrahydrocannabinol in humans. Psychopharmacology, 198(4), 587–603. https://doi.org/https://doi.org/10.1007/s00213-007-1042-2
   PubMed Web of Science ®Google Scholar
• D’Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology, 29(8), 1558–1572. https://doi.org/https://doi.org/10.1038/sj.npp.1300496
   PubMed Web of Science ®Google Scholar
• Felson, J., Adamczyk, A., & Thomas, C. (2019). How and why have attitudes about cannabis legalization changed so much? Social Science Research, 78, 12–27. https://doi.org/https://doi.org/10.1016/j.ssresearch.2018.12.011
   PubMed Web of Science ®Google Scholar
• Foglia, E., Schoeler, T., Klamerus, E., Morgan, K., & Bhattacharyya, S. (2017). Cannabis use and adherence to antipsychotic medication: A systematic review and meta-analysis. Psychological Medicine, 47(10), 1691–1705. https://doi.org/https://doi.org/10.1017/S0033291717000046
   PubMed Web of Science ®Google Scholar
• Gavett, B. E. (2011). Neuropsychological assessment battery. In J. S. Kreutzer, J. DeLuca, & B. Caplan (Eds.), Encyclopedia of clinical neuropsychology (pp. 1761–1765). Springer. https://doi.org/https://doi.org/10.1007/978-0-387-79948-3_2250
   Google Scholar
• Gibbs, M., Winsper, C., Marwaha, S., Gilbert, E., Broome, M., & Singh, S. P. (2015). Cannabis use and mania symptoms: A systematic review and meta-analysis. Journal of Affective Disorders, 171, 39–47. https://doi.org/https://doi.org/10.1016/j.jad.2014.09.016
   PubMed Web of Science ®Google Scholar
• Glickman, M. E., Rao, S. R., & Schultz, M. R. (2014). False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. Journal of Clinical Epidemiology, 67(8), 850–857.
   Google Scholar
• Goldberg, J. F., Garno, J. L., Leon, A. C., Kocsis, J. H., & Portera, L. (1999). A history of substance abuse complicates remission from acute mania in bipolar disorder. The Journal of Clinical Psychiatry, 60(11), 733–740. https://doi.org/https://doi.org/10.4088/JCP.v60n1103
   PubMed Web of Science ®Google Scholar
• Grinspoon, L., & Bakalar, J. B. (1998). The use of cannabis as a mood stabilizer in bipolar disorder: Anecdotal evidence and the need for clinical research. Journal of Psychoactive Drugs, 30(2), 171–177. https://doi.org/https://doi.org/10.1080/02791072.1998.10399687
   PubMed Web of Science ®Google Scholar
• Gruber, A. J., Pope, H. G. Jr., & Brown, M. E. (1996). Do patients use marijuana as an antidepressant? Depression, 4(2), 77–80. https://doi.org/https://doi.org/10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C
   PubMedGoogle Scholar
• Halder, A., Mukhopadhyay, S., Biswas, P. S., & Biswas, A. (2016). Effects of cannabis use on cognitive function and clinical features of bipolar disorder. International Journal of Educational and Psychological Researches, 2(4), 213–218. https://doi.org/https://doi.org/10.4103/2395-2296.189677
   Google Scholar
• Hall, W., & Degenhardt, L. (2014). The adverse health effects of chronic cannabis use. Drug Testing and Analysis, 6(1–2), 39–45. https://doi.org/https://doi.org/10.1002/dta.1506
   PubMed Web of Science ®Google Scholar
• Harvey, P. D., Raykov, T., Twamley, E. W., Vella, L., Heaton, R. K., & Patterson, T. L. (2011). Validating the measurement of real-world functional outcomes: Phase I results of the VALERO study. The American Journal of Psychiatry, 168(11), 1195–1201. https://doi.org/https://doi.org/10.1176/appi.ajp.2011.10121723
   PubMed Web of Science ®Google Scholar
• Harvey, P. D., Raykov, T., Twamley, E. W., Vella, L., Heaton, R. K., & Patterson, T. L. (2013). Factor structure of neurocognition and functional capacity in schizophrenia: A multidimensional examination of temporal stability. Journal of the International Neuropsychological Society, 19(6), 656–663. https://doi.org/https://doi.org/10.1017/S1355617713000179
   PubMed Web of Science ®Google Scholar
• Harvey, P. D., Siever, L. J., Huang, G. D., Muralidhar, S., Zhao, H., Miller, P., Aslan, M., Mane, S., McNamara, M., Gleason, T., Brophy, M., Przygodszki, R., O’Leary, T. J., Gaziano, M., & Concato, J. (2014). The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 165(4), 381–389. https://doi.org/https://doi.org/10.1002/ajmg.b.32242
   Web of Science ®Google Scholar
• Hawton, K., Sutton, L., Haw, C., Sinclair, J., & Harriss, L. (2005). Suicide and attempted suicide in bipolar disorder: A systematic review of risk factors. The Journal of Clinical Psychiatry, 66(6), 693–704. https://doi.org/https://doi.org/10.4088/jcp.v66n0604
   PubMed Web of Science ®Google Scholar
• Healey, C., Peters, S., Kinderman, P., McCracken, C., & Morriss, R. (2009). Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: A qualitative study. Journal of Affective Disorders, 113(1–2), 118–126. https://doi.org/https://doi.org/10.1016/j.jad.2008.05.010
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, H., McCutchan, J. A., Reicks, C., & Grant, I., & HNRC Group. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317–331. https://doi.org/https://doi.org/10.1017/S1355617704102130
   PubMed Web of Science ®Google Scholar
• Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular Psychiatry, 17(6), 642–649. https://doi.org/https://doi.org/10.1038/mp.2011.82
   PubMed Web of Science ®Google Scholar
• Jylhä, P., Rosenström, T., Mantere, O., Suominen, K., Melartin, T., Vuorilehto, M., Holma, M., Riihimäki, K., Oquendo, M. A., Keltikangas-Järvinen, L., & Isometsä, E. T. (2016). Personality disorders and suicide attempts in unipolar and bipolar mood disorders. Journal of Affective Disorders, 190, 632–639. https://doi.org/https://doi.org/10.1016/j.jad.2015.11.006
   PubMed Web of Science ®Google Scholar
• Keefe, R. S. E., Goldberg, T. E., Harvey, P. D., Gold, J. M., Poe, M. P., & Coughenour, L. (2004). The brief assessment of cognition in schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research, 68(2–3), 283–297. https://doi.org/https://doi.org/10.1016/j.schres.2003.09.011
   PubMed Web of Science ®Google Scholar
• Keefe, R. S. E., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., Meltzer, H. Y., Green, M. F., Miller, D. D., Canive, J. M., Adler, L. W., Manschreck, T. C., Swartz, M., Rosenheck, R., Perkins, D. O., Walker, T. M., Stroup, T. S., McEvoy, J. P., & Lieberman, J. A. (2006). Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology, 31(9), 2033–2046. https://doi.org/https://doi.org/10.1038/sj.npp.1301072
   PubMed Web of Science ®Google Scholar
• Keefe, R. S. E., Fox, K. H., Harvey, P. D., Cucchiaro, J., Siu, C., & Loebel, A. (2011). Characteristics of the MATRICS consensus cognitive battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophrenia Research, 125(2–3), 161–168. https://doi.org/https://doi.org/10.1016/j.schres.2010.09.015
   PubMed Web of Science ®Google Scholar
• Kilmer, B., & MacCoun, R. J. (2017). How medical marijuana smoothed the transition to marijuana legalization in the United States. Annual Review of Law and Social Science, 13(1), 181–202.
   PubMedGoogle Scholar
• Koskinen, J., Löhönen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: A meta-analysis. Schizophrenia Bulletin, 36(6), 1115–1130. https://doi.org/https://doi.org/10.1093/schbul/sbp031
   PubMed Web of Science ®Google Scholar
• Kvitland, L. R., Melle, I., Aminoff, S. R., Lagerberg, T. V., Andreassen, O. A., & Ringen, P. A. (2016). Cannabis use in first-treatment bipolar I disorder: Relations to clinical characteristics. Early Intervention in Psychiatry, 10(1), 36–44. https://doi.org/https://doi.org/10.1111/eip.12138
   PubMed Web of Science ®Google Scholar
• Lagerberg, T. V., Icick, R., Andreassen, O. A., Ringen, P. A., Etain, B., Aas, M., Henry, C., Bjella, T. D., Melle, I., & Bellivier, F. (2016). Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder. Journal of Affective Disorders, 190, 286–293. https://doi.org/https://doi.org/10.1016/j.jad.2015.10.023
   PubMed Web of Science ®Google Scholar
• Leite, R. T. P., Nogueira, S. O., Nascimento, J. P. R., Lima, L. S., Nóbrega, T. B., Virgínio, M. S., Moreno, L. M. C., Sampaio, B. H. B., & Souza, F. G. M. (2015). The use of cannabis as a predictor of early onset of bipolar disorder and suicide attempts. Neural Plasticity, 2015, 434127. https://doi.org/https://doi.org/10.1155/2015/434127
   PubMed Web of Science ®Google Scholar
• Leweke, F. M., & Koethe, D. (2008). Cannabis and psychiatric disorders: It is not only addiction. Addiction Biology, 13(2), 264–275. https://doi.org/https://doi.org/10.1111/j.1369-1600.2008.00106.x
   PubMed Web of Science ®Google Scholar
• Mausbach, B. T., Harvey, P. D., Goldman, S. R., Jeste, D. V., & Patterson, T. L. (2007). Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophrenia Bulletin, 33(6), 1364–1372. https://doi.org/https://doi.org/10.1093/schbul/sbm014
   PubMed Web of Science ®Google Scholar
• Mayor’s Committee on Marihuana (1945). The marihuana problem in the city of New York. American Journal of Clinical Pathology, 15(7), 303–304. https://doi.org/https://doi.org/10.1093/ajcp/15.7.303b
   Google Scholar
• McKetin, R., Parasu, P., Cherbuin, N., Eramudugolla, R., & Anstey, K. J. (2016). A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults. Drug and Alcohol Dependence, 169, 134–140. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2016.10.022
   PubMed Web of Science ®Google Scholar
• Ostacher, M. J., Perlis, R. H., Nierenberg, A. A., Calabrese, J., Stange, J. P., Salloum, I., Weiss, R. D., & Sachs, G. S. (2010). Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry, 167(3), 289–297. https://doi.org/https://doi.org/10.1176/appi.ajp.2009.09020299
   PubMed Web of Science ®Google Scholar
• Papini, S., Ruglass, L. M., Lopez-Castro, T., Powers, M. B., Smits, J. A. J., & Hien, D. A. (2017). Chronic cannabis use is associated with impaired fear extinction in humans. Journal of Abnormal Psychology, 126(1), 117–124. https://doi.org/https://doi.org/10.1037/abn0000224
   PubMed Web of Science ®Google Scholar
• Pfennig, A., Alda, M., Young, T., MacQueen, G., Rybakowski, J., Suwalska, A., Simhandl, C., König, B., Hajek, T., O’Donovan, C., Wittekind, D., von Quillfeldt, S., Ploch, J., Sauer, C., & Bauer, M. (2014). Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: No simple answers in complex disease-treatment interplay. International Journal of Bipolar Disorders, 2(1), 16. https://doi.org/https://doi.org/10.1186/s40345-014-0016-7
   Google Scholar
• Pigoni, A., Mandolini, G. M., Delvecchio, G., Bressi, C., Soares, J. C., & Brambilla, P. (2020). A focus on valproate and cognitive deficits in bipolar disorders: A mini-review: Special section on “Translational and Neuroscience Studies in Affective Disorders” Section Editor, Maria Nobile MD, PhD. Journal of Affective Disorders, 261, 277–281. https://doi.org/https://doi.org/10.1016/j.jad.2019.08.008
   PubMed Web of Science ®Google Scholar
• Pinto, J. V., Medeiros, L. S., Santana da Rosa, G., Santana de Oliveira, C. E., Crippa, J. A. de S., Passos, I. C., & Kauer-Sant’Anna, M. (2019). The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression. Neuroscience and Biobehavioral Reviews, 101, 78–84. https://doi.org/https://doi.org/10.1016/j.neubiorev.2019.04.004
   PubMed Web of Science ®Google Scholar
• Pope, H. G., & Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. JAMA, 275(7), 521–527. https://doi.org/https://doi.org/10.1001/jama.1996.03530310027028
   PubMed Web of Science ®Google Scholar
• Quraishi, S., & Frangou, S. (2002). Neuropsychology of bipolar disorder: A review. Journal of Affective Disorders, 72(3), 209–226. https://doi.org/https://doi.org/10.1016/s0165-0327(02)00091-5
   PubMed Web of Science ®Google Scholar
• Reed, A., Zeng, V., Alliey-Rodriguez, N., Tamminga, C., Clementz, B., Pearlson, G., Sweeney, J., Gershon, E., Keshavan, M., & del Re, E. C. (2021). Morphometric attention and language brain correlates in early psychosis with cannabis use and polygenic risk score: A BSNIP study. Biological Psychiatry, 89(9), S242–S243. https://doi.org/https://doi.org/10.1016/j.biopsych.2021.02.608
   Web of Science ®Google Scholar
• Rey, A. A., Purrio, M., Viveros, M.-P., & Lutz, B. (2012). Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology, 37(12), 2624–2634. https://doi.org/https://doi.org/10.1038/npp.2012.123
   PubMed Web of Science ®Google Scholar
• Ringen, P. A., Vaskinn, A., Sundet, K., Engh, J. A., Jónsdóttir, H., Simonsen, C., Friis, S., Opjordsmoen, S., Melle, I., & Andreassen, O. A. (2010). Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychological Medicine, 40(8), 1337–1347. https://doi.org/https://doi.org/10.1017/S0033291709991620
   PubMed Web of Science ®Google Scholar
• Sagar, K. A., Dahlgren, M. K., Racine, M. T., Dreman, M. W., Olson, D. P., & Gruber, S. A. (2016). Joint effects: A pilot investigation of the impact of bipolar disorder and marijuana use on cognitive function and mood. PLOS One, 11(6), e0157060. https://doi.org/https://doi.org/10.1371/journal.pone.0157060
   PubMed Web of Science ®Google Scholar
• Sarvet, A. L., Wall, M. M., Keyes, K. M., Olfson, M., Cerdá, M., & Hasin, D. S. (2018). Self-medication of mood and anxiety disorders with marijuana: Higher in states with medical marijuana laws. Drug and Alcohol Dependence, 186, 10–15. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.01.009
   PubMed Web of Science ®Google Scholar
• Schoeler, T., Kambeitz, J., Behlke, I., Murray, R., & Bhattacharyya, S. (2016). The effects of cannabis on memory function in users with and without a psychotic disorder: Findings from a combined meta-analysis. Psychological Medicine, 46(1), 177–188. https://doi.org/https://doi.org/10.1017/S0033291715001646
   PubMed Web of Science ®Google Scholar
• Schreiner, A. M., & Dunn, M. E. (2012). Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis. Experimental and Clinical Psychopharmacology, 20(5), 420–429. https://doi.org/https://doi.org/10.1037/a0029117
   PubMed Web of Science ®Google Scholar
• Schuermeyer, J., Salomonsen-Sautel, S., Price, R. K., Balan, S., Thurstone, C., Min, S. J., & Sakai, J. T. (2014). Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003–11. Drug and Alcohol Dependence, 140, 145–155. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2014.04.016
   PubMed Web of Science ®Google Scholar
• Sewell, R. A., Skosnik, P. D., Garcia-Sosa, I., Ranganathan, M., & D’Souza, D. C. (2010). [Behavioral, cognitive and psychophysiological effects of cannabinoids: Relevance to psychosis and schizophrenia]. Revista Brasileira De Psiquiatria, 32(Suppl 1), S15–S30.
   PubMedGoogle Scholar
• Solowij, N., & Pesa, N. (2010). Cognitive abnormalities and cannabis use. Revista Brasileira de Psiquiatria, 32(Suppl 1), S31–S40. https://doi.org/https://doi.org/10.1590/S1516-44462010000500006
   PubMedGoogle Scholar
• Sonne, S. C., Brady, K. T., & Morton, W. A. (1994). Substance abuse and bipolar affective disorder. The Journal of Nervous and Mental Disease, 182(6), 349–352. https://doi.org/https://doi.org/10.1097/00005053-199406000-00007
   PubMed Web of Science ®Google Scholar
• Stinson, F. S., Ruan, W. J., Pickering, R., & Grant, B. F. (2006). Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity. Psychological Medicine, 36(10), 1447–1460. https://doi.org/https://doi.org/10.1017/S0033291706008361
   PubMed Web of Science ®Google Scholar
• Strakowski, S. M., DelBello, M. P., Fleck, D. E., Adler, C. M., Anthenelli, R. M., Keck, P. E., Arnold, L. M., & Amicone, J. (2007). Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Archives of General Psychiatry, 64(1), 57–64. https://doi.org/https://doi.org/10.1001/archpsyc.64.1.57
   PubMed Web of Science ®Google Scholar
• Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms, and commentary (3rd ed.). Oxford University Press.
   Google Scholar
• Sublette, M. E., Carballo, J. J., Moreno, C., Galfalvy, H. C., Brent, D. A., Birmaher, B., Mann, J. J., & Oquendo, M. A. (2009). Substance use disorders and suicide attempts in bipolar subtypes. Journal of Psychiatric Research, 43(3), 230–238. https://doi.org/https://doi.org/10.1016/j.jpsychires.2008.05.001
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (2017). Mental health services administration. Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/
   Google Scholar
• Thatcher, J. W., Marchand, W. R., Thatcher, G. W., Jacobs, A., & Jensen, C. (2007). Clinical characteristics and health service use of veterans with comorbid bipolar disorder and PTSD. Psychiatric Services, 58(5), 703–707. https://doi.org/https://doi.org/10.1176/ps.2007.58.5.703
   PubMed Web of Science ®Google Scholar
• Tombaugh, T. N., Kozak, J., & Rees, L. (1999). Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Archives of Clinical Neuropsychology, 14(2), 167–177. https://doi.org/https://doi.org/10.1016/S0887-6177(97)00095-4
   PubMed Web of Science ®Google Scholar
• van Rossum, I., Boomsma, M., Tenback, D., Reed, C., & van Os, J. (2009). Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. The Journal of Nervous and Mental Disease, 197(1), 35–40. https://doi.org/https://doi.org/10.1097/NMD.0b013e31819292a6
   PubMed Web of Science ®Google Scholar
• Vishwakarma, P., Kumar, A., & Mehata, N. (2019). Impact of cannabis use on executive functions in male patients with bipolar disorder: A comparative study. President: Deepak Raheja Vice President: Vishal Chhabra General Secretary: Pankaj Kumar Patron: NK Bohra Joint Secretary: Manushree Gupta, (Vol. 22), 371.
   Google Scholar
• Wagner, T. H., Harris, K. M., Federman, B., Dai, L., Luna, Y., & Humphreys, K. (2007). Prevalence of substance use disorders among veterans and comparable nonveterans from the National Survey on Drug Use and Health. Psychological Services, 4(3), 149–157. https://doi.org/https://doi.org/10.1037/1541-1559.4.3.149
   Google Scholar
• Wechsler, D. (2008). Wechsler Adult Intelligence Scale–Fourth Edition (WAIS–IV). Pearson.
   Google Scholar
• Weiss, R. D., Ostacher, M. J., Otto, M. W., Calabrese, J. R., Fossey, M., Wisniewski, S. R., Bowden, C. L., Nierenberg, A. A., Pollack, M. H., Salloum, I. M., Simon, N. M., Thase, M. E., Sachs, G. S., & STEP-BD Investigators (2005). Does recovery from substance use disorder matter in patients with bipolar disorder? The Journal of Clinical Psychiatry, 66(06), 730–735. https://doi.org/https://doi.org/10.4088/JCP.v66n0609
   PubMedGoogle Scholar
• Zorrilla, I., Aguado, J., Haro, J. M., Barbeito, S., López Zurbano, S., Ortiz, A., López, P., & Gonzalez-Pinto, A. (2015). Cannabis and bipolar disorder: Does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes? Acta Psychiatrica Scandinavica, 131(2), 100–110. https://doi.org/https://doi.org/10.1111/acps.12366
   PubMed Web of Science ®Google Scholar